These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4588113)

  • 21. Effects of alloxan on insulin release by isolated mouse pancreatic islets.
    Fung WP; Mennear JH
    Proc Soc Exp Biol Med; 1974 Sep; 146(4):949-52. PubMed ID: 4607784
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of ethanol and n-butanol on alloxan inhibition of glucose-induced insulin release in isolated pancreatic islets.
    McDaniel ML; Roth CE; Bry CA; Fink CJ; Swanson JA; Lacy PE
    Biochem Pharmacol; 1978; 27(13):1749-51. PubMed ID: 361044
    [No Abstract]   [Full Text] [Related]  

  • 23. Phlorizin: its effect on glucose-induced insulin secretion and protection against the alloxan effect in isolated islets.
    Tomita T
    FEBS Lett; 1976 Jun; 65(2):140-3. PubMed ID: 776692
    [No Abstract]   [Full Text] [Related]  

  • 24. Protein deficiency attenuates the effects of alloxan on insulin secretion and glucose homeostasis in rats.
    Prada FJ; Luciano E; Carneiro EM; Boschero AC; Mello MA
    Physiol Chem Phys Med NMR; 2001; 33(1):73-82. PubMed ID: 11758737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport of L-leucine and D-leucine into pancreatic -cells with reference to the mechanisms of amino acid-induced insulin release.
    Hellman B; Sehlin J; Täljedal IB
    Biochim Biophys Acta; 1972 May; 266(2):436-43. PubMed ID: 4624901
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective loss of glucose-induced amplification of insulin secretion in mouse pancreatic islets pretreated with sulfonylurea in the absence of fuels.
    Urban KA; Panten U
    Diabetologia; 2005 Dec; 48(12):2563-6. PubMed ID: 16283243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Close interrelationships among glucose oxidation, glucose-induced 45Ca uptake and insulin release of presumed pancreatic beta-cell mass.
    Ishibashi F; Sato T; Onari K; Tsubota M; Kawate R
    Horm Metab Res; 1980 Mar; 12(3):89-94. PubMed ID: 6989737
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of cyclic AMP and alloxan on insulin secretion in isolated rat islets perifused in vitro.
    Tomita T; Scarpelli DG
    Endocrinology; 1977 May; 100(5):1327-33. PubMed ID: 191240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation by alloxan of glucagon and insulin secretion in the isolated perfused rat pancreas.
    Goto Y; Seino Y; Taminato T; Inoue Y; Kadowaki S; Mori K; Imura H
    Endocrinology; 1978 May; 102(5):1496-500. PubMed ID: 369831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects and fate of succinate esters in pancreatic islets.
    Malaisse WJ; Sener A
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E434-40. PubMed ID: 8460691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of priming with D-glucose on insulin secretion from rat pancreatic islets: increased responsiveness to other secretagogues.
    Grill V; Rundfeldt M
    Endocrinology; 1979 Oct; 105(4):980-7. PubMed ID: 89958
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of anti-microtubular agents on alloxan stimulation and inhibition of glucose-induced insulin release in vitro.
    Ishibashi F
    Hiroshima J Med Sci; 1982 Jun; 31(2):91-5. PubMed ID: 6752103
    [No Abstract]   [Full Text] [Related]  

  • 34. Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
    Lenzen S; Freytag S; Panten U; Flatt PR; Bailey CJ
    Pharmacol Toxicol; 1990 Mar; 66(3):157-62. PubMed ID: 2185463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of alloxan in mice.
    Ahrén B; Sundkvist G
    Int J Pancreatol; 1995 Apr; 17(2):197-201. PubMed ID: 7622942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to alloxan of tumoral insulin-producing cells.
    Sener A; Malaisse WJ
    FEBS Lett; 1985 Dec; 193(2):150-2. PubMed ID: 3905435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of barbituric-acid protection against inhibition by alloxan of glucose-induced insulin release.
    Weaver DC; McDaniel ML; Lacy PE
    Diabetes; 1978 Feb; 27(2):71-7. PubMed ID: 342321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucose and alloxan interactions in the pancreatic islets.
    Zawalich WS; Beidler LM
    Am J Physiol; 1973 Apr; 224(4):963-6. PubMed ID: 4266918
    [No Abstract]   [Full Text] [Related]  

  • 39. Ionic basis of phenytoin sodium inhibition of insulin secretion in pancreatic islets.
    Pace CS; Livingston E
    Diabetes; 1979 Dec; 28(12):1077-82. PubMed ID: 389714
    [No Abstract]   [Full Text] [Related]  

  • 40. Anomeric specificity of D-mannose metabolism in pancreatic islets.
    Sener A; Malaisse-Lagae F; Lebrun P; Herchuelz A; Leclercq-Meyer V; Malaisse WJ
    Biochem Biophys Res Commun; 1982 Oct; 108(4):1567-73. PubMed ID: 6758784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.